| Abstrakt: |
Objective: Chronic non-specific low back pain is a very common musculoskeletal condition that affects the quality of life. It is critical to be treated with effective, safe and minimally invasive treatments. In this study, we analyzed the impact of paravertebral ozone/oxygen (O3/O2) treatment injection treatment on distress and disability in patients with chronic non-specific low back pain. Materials and Methods: From January 2019 to December 2021, 426 patients who underwent paravertebral ozone injections due to low back pain were examined retrospectively; 305 patients who met the study criteria were included. The patients were injected with 15 Î1/4g (50 mL) O3/O2 gas in the paravertebral muscle. Paravertebral O3/O2 injections were administered once a week for 5 weeks. Visual analog scale (VAS)-resting, VAS-activity and Istanbul Low Back Pain Disability Index (ILBPDI) were recorded at pre-treatment, post-treatment, and 6-month follow-ups. Results: Of the patients included in the study, 158 (51.8%) were female, 147 (48.2%) were male and the mean age of all patients was 45.6±8.8. VAS-resting, VAS-activity decreased statistically significantly after treatment and 6 months after treatment compared to pretreatment (p<0.001). The mean ILBPDI score of the patients decreased statistically significantly after the treatment and at the 3rd month and 6th month after the treatment compared with the pre-treatment (p<0.001). There was no significant difference between the post-treatment and posttreatment 6-month measurements. Conclusion: In our study, it was found that paravertebral O3/O2 therapy for treating chronic nonspecific low back pain was effective in improving pain, functional status and activities of daily living, and its effect continued in the long term. [ABSTRACT FROM AUTHOR] |
